The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

/C O R R E C T I O N -- Nu Skin Enterprises, Inc./

Thursday, August 01, 2013

/C O R R E C T I O N -- Nu Skin Enterprises, Inc./

06:35 EDT Thursday, August 01, 2013

In the news release, Nu Skin Enterprises Reports Record Second-Quarter Results, issued 01-Aug-2013 by Nu Skin Enterprises, Inc. over PR Newswire, the earnings release included an inadvertent typographical error. While the annual guidance of $2.91 to $2.95 billion in revenue and the annual earnings per share of $5.05 to $5.15, as well as the revenue guidance for the third quarter of $790 to $810 million were correctly stated, the last sentence in the third paragraph of the Outlook section contained an error. The earnings per share guidance for the third quarter should have been "$1.35 to $1.40." The complete, corrected release follows:

Nu Skin Enterprises Reports Record Second-Quarter Results Company raises annual sales forecast $90 million

PROVO, Utah, Aug. 1, 2013 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced record second-quarter results with revenue of $682.9 million, a 15 percent increase over the prior-year period. Revenue for the quarter was negatively impacted 3 percent by foreign currency fluctuations. Quarterly earnings per share increased 30 percent to $1.22 from $0.94 in the prior year.

"We are extremely pleased with second-quarter results that reflect the strong momentum of the business," said Truman Hunt, president and chief executive officer. "We are particularly pleased with these results given the record regional ageLOC product launches in the prior-year period. Additionally, we generated continued growth of both our consumer and sales leader base, reflected in 32 percent growth in actives and 23 percent growth in sales leaders. Overall, we saw healthy trends throughout the global business, particularly in the Greater China, North Asia and Americas regions."

"Sales force enthusiasm for the introduction of our ageLOC TR90 weight management system bodes well for a strong second half of the year. We plan to begin the limited-time offer of ageLOC TR90 in September and believe this new product provides an ideal vehicle for us to increase our presence in the growing weight management category."

Regional Results

Greater China. In Greater China, second-quarter revenue increased 35 percent to $269.1 million, compared to $199.7 million in the prior year, which included approximately $100 million in product launch revenue. The region's results were negatively impacted 3 percent by foreign currency fluctuations. The sales leader count in the region improved 51 percent, while the number of actives increased 121 percent compared to the prior year.

North Asia. Second-quarter revenue in North Asia was $196.8 million, compared to $177.7 million for the same period of 2012. The region's results were negatively impacted 12 percent by foreign currency fluctuations. Japan local-currency revenue improved 5 percent and South Korea generated local-currency revenue growth of 54 percent. The number of sales leaders in the region was up 21 percent while the number of actives improved 15 percent.

South Asia/Pacific. Revenue in South Asia/Pacific was $85.9 million, a 13 percent decline compared to the prior year. Revenue in the prior year included approximately $40 million in product launch sales. Results were not notably impacted by foreign currency fluctuations. The region's second-quarter sales leaders decreased 20 percent while actives increased 16 percent compared to the same period in 2012.

Americas. Revenue in the Americas improved 17 percent to $84.3 million, compared to $71.8 million in the prior-year period. The region's results were negatively impacted 5 percent by foreign currency fluctuations. The number of sales leaders in the region improved 16 percent while the number of actives increased 3 percent compared to the prior year.

EMEA. Revenue in the EMEA region was $46.8 million, a 2 percent improvement over the prior-year period. The region's results were positively impacted 1 percent by foreign currency fluctuations. Sales leaders decreased 3 percent, while actives increased 4 percent compared to the prior year.   

Operational Performance

The company's operating margin was 16.8 percent for the quarter, compared to 16.5 percent, while gross margin was 83.7 percent, compared to 83.9 percent in the prior year. Selling expenses, as a percent of revenue, were 45.2 percent in the second quarter. General and administrative expenses, as a percent of revenue, improved to 21.7 percent from 22.3 percent in the prior-year period. Other income (expense) reflected an expense of $1.1 million compared to a $3.4 million expense in the prior year. 

The company's income tax rate for the quarter was 34.4 percent compared to 36.1 percent in the prior-year period. The company's cash and short-term investment position at the end of the quarter was $411.4 million. Dividend payments were $17.6 million.

Outlook

"As we look to the back half of the year, we are ramping up for what we expect to be our largest-ever product launch," said Hunt. "Given the growth momentum of the business, we are again increasing the sales forecast for the remainder of the year. We expect the upcoming launch of ageLOC TR90 and the strength of the business in several key markets will lead to another record year as annual revenue will approach the $3 billion mark," Hunt concluded.

"Given the significant growth in our actives, we are raising our annual sales guidance by $90 million to $2.91 to $2.95 billion," said Ritch Wood, chief financial officer. We now expect earnings per share to be $5.05 to $5.15 and continue to project a negative 5 percent foreign currency impact to annual revenue."

"In the third quarter, we will introduce ageLOC TR90 for a limited time in the Greater China region and much of South Asia in advance of our global convention," continued Wood. "With these ageLOC TR90 sales, we anticipate third-quarter revenue to be between $790 and $810 million, with a negative currency impact to revenue of 6 to 7 percent. We anticipate earnings per share to be $1.35 to $1.40 for the quarter," concluded Wood.

The company's management will host a webcast with the investment community on Aug. 1, 2013, at 11 a.m. EDT. Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on Nu Skin Enterprises' website, http://ir.nuskin.com. An archive of the webcast will be available at this same URL through Aug. 16, 2013. 

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC® suite of products including the ageLOC® R2 nutritional supplement, ageLOC® Galvanic Spa System and ageLOC® Galvanic Body Spa?, as well as the ageLOC® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.

Please Note: This press release, particularly the "Outlook" section, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies, new product introductions and growth in the company's markets, including mainland China; statements of projections regarding revenue, earnings per share, foreign currency impact and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

  • any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis;
  • risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;
  • challenging economic conditions globally;
  • risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;
  • risks associated with general inquiries and complaints to consumer protection agencies in Japan regarding the activities of some distributors;
  • risks associated with our ability to manage rapid growth, particularly in our greater China region;
  • regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;
  • continued regulatory scrutiny and investigations in Mainland China, which have from time to time in the past, and could in the future, negatively impact the company's business, including the interruption of sales activities in stores, loss of licenses, and the imposition of fines;
  • adverse publicity related to the company's business, products, industry or any legal actions or complaints by distributors or others;
  • any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and
  • continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission.  The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

 

 

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

For the Second Quarters Ended June 30, 2013 and 2012

(in thousands, except per share amounts)

2013

2012

Revenue:

        Greater China

$               269,146

$                199,728

        North Asia

196,757

177,695

        South Asia/Pacific

85,916

98,344

        Americas

84,289

71,766

        EMEA

46,819

45,702

Total revenue

682,927

593,235

Cost of sales

111,273

95,584

Gross profit

571,654

497,651

Operating expenses:

        Selling expenses

308,769

267,363

        General and administrative expenses

148,302

132,376

Total operating expenses

457,071

399,739

Operating income

114,583

97,912

Other income (expense), net

(1,187)

(3,369)

Income before provision for income taxes

113,396

94,543

Provision for income taxes

38,961

34,136

Net income

$                 74,435

$                  60,407

Net income per share:

        Basic

$                     1.27

$                      0.98

        Diluted

$                     1.22

$                      0.94

Weighted average common shares outstanding:

        Basic

58,620

61,706

        Diluted

61,121

64,230

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

For the Six Month Periods Ended June 30, 2013 and 2012

(in thousands, except per share amounts)

2013

2012

Revenue:

        Greater China

$               444,852

$               292,339

        North Asia

384,950

359,895

        South Asia/Pacific

153,158

175,665

        Americas

160,830

138,106

        EMEA

89,231

89,232

Total revenue

1,233,021

1,055,237

Cost of sales

201,318

171,340

Gross profit

1,031,703

883,897

Operating expenses:

        Selling expenses

550,652

469,898

        General and administrative expenses

283,809

244,424

Total operating expenses

834,461

714,322

Operating income

197,242

169,575

Other income (expense), net

(1,075)

266

Income before provision for income taxes

196,167

169,841

Provision for income taxes

67,450

61,605

Net income

$               128,717

$               108,236

Net income per share:

        Basic

$                     2.20

$                     1.75

        Diluted

$                     2.11

$                     1.67

Weighted average common shares outstanding:

        Basic

58,487

62,016

        Diluted

60,882

64,773

NU SKIN ENTERPRISES, INC.

Consolidated Balance Sheets (Unaudited)

(in thousands)

June 30, 2013

December 31, 2012

ASSETS

Current assets:

        Cash and cash equivalents

$                402,678

$                320,025

        Current investments

8,754

13,378

        Accounts receivable

59,043

36,850

        Inventories, net

178,183

135,874

        Prepaid expenses and other

117,138

93,276

765,796

599,403

Property and equipment, net

304,619

229,787

Goodwill

112,446

112,446

Other intangible assets, net

87,644

92,518

Other assets

122,202

118,753

                Total assets

$             1,392,707

$             1,152,907

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

        Accounts payable

$                  48,954

$                  47,882

        Accrued expenses

355,215

233,202

        Current portion of long-term debt

69,461

39,019

473,630

320,103

Long-term debt

128,664

154,963

Other liabilities

98,326

87,229

                Total liabilities

700,620

562,295

Stockholders' equity:

        Class A common stock

91

91

        Additional paid-in capital

332,588

317,293

       Treasury stock, at cost

(718,800)

(714,853)

        Accumulated other comprehensive loss

(55,272)

(51,822)

        Retained earnings

1,133,480

1,039,903

692,087

590,612

                Total liabilities and stockholders' equity

$             1,392,707

$             1,152,907

NU SKIN ENTERPRISES, INC.

Actives/Sales Leaders Statistics

As of June 30, 2013

As of June 30, 2012

% Increase (Decrease)

Actives

Sales Leaders

Actives

Sales Leaders

Actives

Sales Leaders

Greater China

376,000

30,455

170,000

20,182

121.2%

50.9%

North Asia

389,000

17,372

337,000

14,370

15.4%

20.9%

South Asia/Pacific

114,000

7,120

99,000

8,856

15.2%

(19.6%)

Americas

176,000

6,954

170,000

5,994

3.5%

16.0%

EMEA

124,000

4,484

119,000

4,626

4.2%

(3.1%)

Total

1,179,000

66,385

895,000

54,028

31.7%

22.9%

"Actives" are persons who purchased products directly from the company during the previous three months.

"Sales Leaders" are persons who have completed and who maintain specified sales requirements. Sales Leaders include our independent distributors who have completed and who maintain specified sales requirements, and our sales employees and contractual sales promoters in China, who have completed certain qualification requirements.

SOURCE Nu Skin Enterprises, Inc.

For further information: Investors, Scott Pond (801) 345-2657, spond@nuskin.com, or Media, Kara Schneck (801) 345-2116, kschneck@nuskin.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections